Bruce Ponder
Genetic Susceptibility to Cancer
Cancer Research UK Cambridge Research InstituteLi Ka Shing Centre
Robinson Way
Cambridge
CB2 0RE
Research Goals
1. To identify the genes that underlie susceptibility to the common cancers.
2. To elucidate the spectrum of rare and common genetic variation that underlies susceptibility.
3. To develop phenotypic assays that are practicable on an epidemiological scale to assist in the search for these genes.
4. To use knowledge of susceptibility genes to elucidate new mechanisms of carcinogenesis.
5. To explore the use of genetic information to define groups at different risk in the population, and so to design programmes of screening and prevention.
Research is conducted in close collaboration with Doug Easton and Paul Pharoah at the Strangeways Research Laboratory.
Qualifications and Personal History
MB; BChir; PhD
Fellow of the Royal College of Physicians
Fellow of the Royal College of Pathologists
Founder Fellow of the Academy of Medical Sciences
Fellow of the Royal Society.
Head of Department of Oncology, University of Cambridge
Honorary Consultant Physician, Cambridge University Teaching Hospitals Foundation Trust
Co-Director, Hutchison/MRC Research Centre
Co-Director, Strangeways Research Laboratories
1990 - Awarded the Cancer Research UK Gibb Fellowship
1993 - Professor of Human Cancer Genetics
1998 - Professor of Oncology, University of Cambridge
2007 - Appointed Li Ka Shing Professor of Oncology, University of Cambridge
2008 - Knighthood for 'Services to Medicine'
2005 to present - Director, Cancer Research UK Cambridge Research Institute
Listen to Bruce Ponder talk about the Cambridge Research Institute and research at the Institute
